TIE1 Promotes Primary Tumor Growth by Inhibiting Apoptosis and Activating the AKT ‐ p70S6K Signaling Pathway in Breast Cancer
Genes to Cells · 2025
DOI: 10.1111/gtc.70062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2025. Verfasst von Kazushi Azuma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, Japan. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Triple Negative Breast Neoplasms, Ribosomal Protein S6 Kinases, 70-kDa. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Waseda University Grant for Special Research Projects, Translational Research Programs from Fukushima Prefecture, MEXT Project for promoting public utilization of advanced research infrastructure (Program for supporting construction of core facilities).
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is the most aggressive molecular subtype among all breast cancer types. Its treatment remains a significant challenge due to the lack of clearly defined molecular targets. We previously reported that lung‐metastatic cell lines, established via orthotopic transplantation of a TNBC cell line, showed high expression of the TIE1 receptor‐tyrosine kinase. In this study, we demonstrated that TIE1 expression correlates with poor prognosis in breast cancer patients and is highly elevated in the Claudin‐low subtype, which largely overlaps with TNBC. Notably, TIE1 expression promoted tumorigenicity in a breast cancer cell line. Furthermore, in primary tumors formed by TIE1‐expressing cells, we observed TIE1 cleavage, reduced apoptosis, and activation of the AKT‐p70S6K signaling pathway. Our findings suggest that TIE1 may serve as a potential molecular target and biomarker for Claudin‐low type breast cancer, and further research could have significant implications for its treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
- Translational Research Center, Fukushima Medical University, Fukushima, Japan.
- Department of Oncogenesis and Growth Regulation, Research Institute, Osaka International Cancer Institute, Osaka, Japan.
ORCID-Profile: Kentaro Semba
Förderung
- Waseda University Grant for Special Research Projects
- Translational Research Programs from Fukushima Prefecture
- MEXT Project for promoting public utilization of advanced research infrastructure (Program for supporting construction of core facilities)
Zitieren
APA
Azuma, K., Matsuyama, T., Watanabe, S., Semba, K., & Nakayama, J. (2025). TIE1 Promotes Primary Tumor Growth by Inhibiting Apoptosis and Activating the AKT ‐ p70S6K Signaling Pathway in Breast Cancer. Genes to Cells. https://doi.org/10.1111/gtc.70062
Vancouver
Azuma K, Matsuyama T, Watanabe S, Semba K, Nakayama J. TIE1 Promotes Primary Tumor Growth by Inhibiting Apoptosis and Activating the AKT ‐ p70S6K Signaling Pathway in Breast Cancer. Genes to Cells. 2025. doi:10.1111/gtc.70062
BibTeX
@article{Azuma2025,
author = {Azuma, Kazushi and Matsuyama, Takaya and Watanabe, Shinya and Semba, Kentaro and Nakayama, Jun},
title = {TIE1 Promotes Primary Tumor Growth by Inhibiting Apoptosis and Activating the AKT ‐ p70S6K Signaling Pathway in Breast Cancer},
journal = {Genes to Cells},
year = {2025},
doi = {10.1111/gtc.70062}
}
EUVIMED